Day: August 23, 2021

Vitru Limited Enters into a Definitive Agreement for the Business Combination with Unicesumar

Vitru Limited Enters into a Definitive Agreement for the Business Combination with Unicesumar

FLORIANÓPOLIS, Brazil, Aug. 23, 2021 (GLOBE NEWSWIRE) — Vitru Limited, or Vitru (Nasdaq: VTRU), today announced that it entered into a definitive agreement for a business combination, through its wholly-owned subsidiary Vitru Brasil Empreendimentos, Participações e Comércio S.A., of 100% of the total share capital of CESUMAR – Centro de Ensino Superior de Maringá Ltda, or “Unicesumar”.          Unicesumar is a leading and fast-growing higher education institution in Brazil focused on the distance learning market, founded 30 years ago in Maringá/PR and led by the Matos Family since then. As of March 31, 2021, it had 760 hubs and 331 thousand students, including 314 thousand in digital education. According to the latest INEP higher education census released in Sept. 2020 by the Brazilian Ministry of Education (Ministério da Educação),...

Continue reading

Quipt Home Medical Reports Record Third Quarter Fiscal 2021 Financial Results

Quipt Home Medical Reports Record Third Quarter Fiscal 2021 Financial Results

Posts Revenue Growth of 41% and Adjusted Ebitda Growth of 21% Strong Organic Growth Of 11% YTD as Compared to 2020 CINCINNATI, Aug. 23, 2021 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced its third quarter fiscal 2021 financial results and operational highlights. These results pertain to the three and six months ended June 30, 2021 and are reported in U.S. Dollars. Quipt will host its Quarterly Earnings Conference Call on Tuesday, August 24, 2021 at 10:00 a.m. (ET). The dial-in number is 1 (800) 309-4610 or 1 (604) 638-5340. Financial Highlights: Revenue for Q3 2021 was $26.2 million compared to $18.6 million for Q3 2020, representing a 41% increase in revenue year-over-year....

Continue reading

Medolife Rx Reports Second Quarter 2021 Financial and Operational Results, Schedules Conference Call With Investment Community

Medolife Rx Reports Second Quarter 2021 Financial and Operational Results, Schedules Conference Call With Investment Community

BURBANK, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today financial results for the second quarter of 2021, and provided an operational update. Second Quarter 2021 Highlights: ·         Total revenue generated was USD $116,869; ·         Gross margins remained above 60%; ·         Cash on hand at the end of the quarter was over USD $277,000; ·         Received a response from the U.S. Food and Drug Administration (FDA) on Pre-Investigational New Drug (Pre-IND) submission on Escozine® validating proof-of-concept study; ·         Signed product endorsement agreement with Tony Hawk; ·        ...

Continue reading

NuVista Energy Ltd. Releases 2020 ESG Report

NuVista Energy Ltd. Releases 2020 ESG Report

CALGARY, Alberta, Aug. 23, 2021 (GLOBE NEWSWIRE) — NuVista Energy Ltd. (“NuVista” or the “Company”) (TSX:NVA) is pleased to announce the release of our 2020 Environmental, Social, and Governance (“ESG”) Report. This report, available for viewing on NuVista’s website, highlights our ESG performance through 2019 and 2020. We are proud to share the progress we’ve made on advancing our ESG priorities. 2020 ESG Highlights include: Over 50% reduction in annual Greenhouse Gas Emissions Intensity (Scope 1) from 2012 to 2020; Continued our commitment to responsibly abandoning and reclaiming inactive wells and facilities in 2020 by investing over $11 million in abandonment and reclamation work; Developed a cultural awareness program for staff centred on education to create understanding, respect, and appreciation for Indigenous cultures;...

Continue reading

Fanhua Announces Quarterly Cash Dividend of US$0.15 per ADS for the Second Quarter of 2021

Fanhua Announces Quarterly Cash Dividend of US$0.15 per ADS for the Second Quarter of 2021

GUANGZHOU, China, Aug. 23, 2021 (GLOBE NEWSWIRE) — The board of directors of Fanhua Inc. (“Fanhua” or “the Company”) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that its Board of Directors (the “Board”) has declared a quarterly dividend of US$0.0075 per ordinary share, or US$0.15 per ADS for the second quarter of 2021. The dividend is payable on or around September 23, 2021 to shareholders of record on September 7, 2021. About Fanhua Inc. Fanhua Inc. is a leading independent financial services provider. Through our online platforms and offline sales and service network, we offer a wide variety of financial products and services to individuals, including life and property and casualty insurance products. We also provide insurance claims adjusting services, such as damage assessments,...

Continue reading

Class 1 Nickel Announces Execution of Definitive Agreement to Acquire Strategic Portfolio of Mineral Claims in Ontario and Quebec

Class 1 Nickel Announces Execution of Definitive Agreement to Acquire Strategic Portfolio of Mineral Claims in Ontario and Quebec

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) — Class 1 Nickel and Technologies Limited (CSE: NICO/ OTCQB: NICLF) (the “Company” or “Class 1 Nickel”) is pleased to announce that it has entered into a definitive agreement with Platinum Group Elements Limited (“PGEL”) providing for the acquisition (the “Acquisition”) by the Company of a strategic project portfolio of adjacent and adjoining claims to the Company’s Alexo Dundonald project in Timmins, Ontario, as well as adjacent and adjoining claims to the Company’s Somanike project in Quebec, and a complimentary primary PGE project in Sudbury Ontario (collectively, the “Properties”). The consideration for the Acquisition consists of a cash payment of Cdn$550,000 and the issuance of an aggregate...

Continue reading

Seacoast Announces the Acquisitions of Sabal Palm Bancorp, Inc. and Business Bank of Florida, Corp.

Seacoast Announces the Acquisitions of Sabal Palm Bancorp, Inc. and Business Bank of Florida, Corp.

Establishes Presence in Growing and Affluent Sarasota County Advances Market Share Expansion in Brevard County, the Silicon Valley of the Aerospace Industry STUART, Fla., Aug. 23, 2021 (GLOBE NEWSWIRE) — Seacoast Banking Corporation of Florida (“Seacoast”) (NASDAQ: SBCF), the holding company for Seacoast National Bank (“Seacoast Bank”), announced today that it has entered into two separate definitive agreements to acquire Sabal Palm Bancorp, Inc. (“Sabal Palm”), parent company of Sabal Palm Bank based in Sarasota, FL and Business Bank of Florida, Corp. (“BBFC”), parent company of Florida Business Bank based in Melbourne, FL. The proposed transactions will deepen Seacoast’s presence in Brevard County and provide an entry into the desirable Sarasota market. Upon the completion of each acquisition, the banks will merge with and into...

Continue reading

Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer’s Disease Summit

Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer’s Disease Summit

Presentation to highlight the potential of early clinical assessment of biomarkers to drive development of Alzheimer’s disease therapies CAMBRIDGE, Mass., Aug. 23, 2021 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced participation in the Annual Biomarkers for Alzheimer’s Disease Summit taking place virtually August 25-26, 2021. Chris Winrow, Ph.D., Head of Translational Medicine, will present on biomarker translation and the potential that early clinical assessment of biomarkers has to drive development of Alzheimer’s disease therapies, and Juli Jones, Ph.D., Head of Disease Biology, will be leading a session exploring the utilization of omics platforms in drug discovery. Presentation Details:         Title: Exploring...

Continue reading

Genetron Health to Host Calls Following Earnings and Participate in an Upcoming Investor Conference

Genetron Health to Host Calls Following Earnings and Participate in an Upcoming Investor Conference

BEIJING, Aug. 23, 2021 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will host calls with various brokers following second quarter earnings and participate in an investor conference with Wells Fargo. Management will host calls following earnings, with: UBS at 10:00 AM HKT on August 25thHaitong Securities / CICC at 2:00 PM HKT on August 25thCitic Securities at 3:30 PM HKT on August 25thGuggenheim Securities at 10:15 AM EST on September 23rd Additionally, the details related to the management team’s participation in an upcoming investor conference are as follows: Conference:...

Continue reading

Fanhua Reports Second Quarter and First Half 2021 Unaudited Financial Results

Fanhua Reports Second Quarter and First Half 2021 Unaudited Financial Results

GUANGZHOU, China, Aug. 23, 2021 (GLOBE NEWSWIRE) — Fanhua Inc., (Nasdaq: FANH), (the “Company” or “Fanhua”), a leading independent financial services provider in China, today announced its unaudited financial results for the second quarter and first half ended June 30, 20211. Financial Highlights for the Second Quarter of 2021: (In thousands, except per ADS) 2020Q2(RMB) 2021Q2(RMB) 2021Q2(US$) Change % Total net revenues 881,545 689,919 106,855 (21.7 ) Operating income 96,942 51,005 7,900 (47.4 ) Share of income of affiliates 4,487 10,965 1,698 144.4   Net income attributable to the Company’s shareholders 99,313 67,405 10,440 (32.1 ) Diluted net income per ADS 1.85 1.25 0.19 (32.4 ) Cash, cash equivalents and short- term investments (As of June 30, 2020 and 2021) 1,655,866 1,447,685 224,218 (12.6 ) Financial Highlights...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.